Literature DB >> 25696078

The NVVC guidelines for the management of patients with ST-elevation acute coronary syndromes (STE-ACS).

F W H M Bär.   

Abstract

Entities:  

Year:  2002        PMID： 25696078      PMCID： PMC2499691     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  32 in total

1.  Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences.

Authors:  S G Ellis; E R Da Silva; C M Spaulding; M Nobuyoshi; B Weiner; J D Talley
Journal:  Am Heart J       Date:  2000-06       Impact factor: 4.749

2.  Volume-outcome relation for physicians and hospitals performing angioplasty for acute myocardial infarction in New York state.

Authors:  B A Vakili; R Kaplan; D L Brown
Journal:  Circulation       Date:  2001-10-30       Impact factor: 29.690

3.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.

Authors:  W D Weaver; R J Simes; A Betriu; C L Grines; F Zijlstra; E Garcia; L Grinfeld; R J Gibbons; E E Ribeiro; M A DeWood; F Ribichini
Journal:  JAMA       Date:  1997-12-17       Impact factor: 56.272

4.  Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.

Authors:  E J Topol
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

5.  Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group.

Authors:  A W van 't Hof; A Liem; M J de Boer; F Zijlstra
Journal:  Lancet       Date:  1997-08-30       Impact factor: 79.321

6.  Time to presentation with acute myocardial infarction in the elderly: associations with race, sex, and socioeconomic characteristics.

Authors:  S E Sheifer; S S Rathore; B J Gersh; K P Weinfurt; W J Oetgen; J A Breall; K A Schulman
Journal:  Circulation       Date:  2000-10-03       Impact factor: 29.690

7.  Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial.

Authors:  W D Weaver; M Cerqueira; A P Hallstrom; P E Litwin; J S Martin; P J Kudenchuk; M Eisenberg
Journal:  JAMA       Date:  1993-09-08       Impact factor: 56.272

8.  Value of admission electrocardiogram in predicting outcome of thrombolytic therapy in acute myocardial infarction. A randomized trial conducted by The Netherlands Interuniversity Cardiology Institute.

Authors:  F W Bar; F Vermeer; C de Zwaan; M Ramentol; S Braat; M L Simoons; W T Hermens; A van der Laarse; F W Verheugt; X H Krauss
Journal:  Am J Cardiol       Date:  1987-01-01       Impact factor: 2.778

9.  Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups.

Authors:  R J Gibbons; D R Holmes; G S Reeder; K R Bailey; M R Hopfenspirger; B J Gersh
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

10.  Emergency department thrombolysis critical pathway reduces door-to-drug times in acute myocardial infarction.

Authors:  C P Cannon; E B Johnson; M Cermignani; B M Scirica; M J Sagarin; R M Walls
Journal:  Clin Cardiol       Date:  1999-01       Impact factor: 2.882
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.